A double blind, randomized, cross-over placebo controlled pilot study to investigate the subjective and physiological efficacy and safety of Lybridos in healthy female subjects with Female Sexual Dysfunction.
Completed
- Conditions
- Female Sexual Dysfunction (FSD), Hypoactive Sexual Desire Disorder (HSDD), Female Sexual Arousal Disorder (FSAD)
- Registration Number
- NL-OMON26110
- Lead Sponsor
- Emotional Brain BV
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 13
Inclusion Criteria
Thirteen (13) premenopausal and postmenopausal women with Hypoactive Sexual Desire Disorder (HSDD), with or without Female Sexual Arousal Disorder (FSAD).
Exclusion Criteria
Subjects will not be eligible for inclusion if one of the following criteria applies:
1. Use of oral contraception containing anti-androgens (Like Diane 35 or Minerva);
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate efficacy of Lybridos on physiological and subjective indices of sexual arousal in healthy female subjects with Female Sexual Dysfunction.
- Secondary Outcome Measures
Name Time Method 1. To investigate Lybridos’ influence on attentional bias for erotic stimuli;<br /><br>2. To evaluate the safety of Lybridos.<br>